P. Vreken

7.2k total citations
81 papers, 4.5k citations indexed

About

P. Vreken is a scholar working on Molecular Biology, Clinical Biochemistry and Oncology. According to data from OpenAlex, P. Vreken has authored 81 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 41 papers in Clinical Biochemistry and 15 papers in Oncology. Recurrent topics in P. Vreken's work include Metabolism and Genetic Disorders (41 papers), Biochemical and Molecular Research (28 papers) and Peroxisome Proliferator-Activated Receptors (23 papers). P. Vreken is often cited by papers focused on Metabolism and Genetic Disorders (41 papers), Biochemical and Molecular Research (28 papers) and Peroxisome Proliferator-Activated Receptors (23 papers). P. Vreken collaborates with scholars based in Netherlands, United Kingdom and United States. P. Vreken's co-authors include Ronald J. A. Wanders, André B. P. Kuilenburg, Hans R. Waterham, A. H. van Gennip, Albert H. Gennip, P. G. Barth, Sacha Ferdinandusse, Ronney A. De Abreu, Rutger Meinsma and E.G. van Grunsven and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Genetics.

In The Last Decade

P. Vreken

81 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Vreken Netherlands	34	3.3k	1.2k	942	594	505	81	4.5k
Ilmo E. Hassinen Finland	40	3.5k 1.1×	1.2k 1.0×	449 0.5×	832 1.4×	444 0.9×	170	5.8k
Myriam Baes Belgium	44	4.5k 1.4×	778 0.7×	641 0.7×	1.4k 2.4×	496 1.0×	148	6.8k
Simone Denis Netherlands	37	2.5k 0.8×	1.1k 1.0×	416 0.4×	650 1.1×	316 0.6×	80	3.6k
Xavier Testar Spain	40	3.0k 0.9×	818 0.7×	303 0.3×	980 1.6×	449 0.9×	91	4.8k
Jun‐ichi Nezu Japan	34	2.7k 0.8×	1.9k 1.6×	2.8k 3.0×	380 0.6×	510 1.0×	54	6.2k
Sacha Ferdinandusse Netherlands	47	5.5k 1.7×	2.6k 2.2×	719 0.8×	1.3k 2.3×	590 1.2×	173	7.5k
Gian C. Gazzola Italy	33	2.0k 0.6×	803 0.7×	433 0.5×	556 0.9×	288 0.6×	83	3.5k
C. Charpentier France	26	1.2k 0.4×	1.0k 0.9×	463 0.5×	285 0.5×	204 0.4×	85	2.3k
Michael S. Kilberg United States	31	2.9k 0.9×	301 0.3×	336 0.4×	695 1.2×	472 0.9×	46	4.8k
R. B. H. Schutgens Netherlands	40	5.0k 1.5×	2.4k 2.1×	235 0.2×	1.1k 1.9×	223 0.4×	112	5.9k

Countries citing papers authored by P. Vreken

Since Specialization

Citations

This map shows the geographic impact of P. Vreken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Vreken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Vreken more than expected).

Fields of papers citing papers by P. Vreken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Vreken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Vreken. The network helps show where P. Vreken may publish in the future.

Co-authorship network of co-authors of P. Vreken

This figure shows the co-authorship network connecting the top 25 collaborators of P. Vreken. A scholar is included among the top collaborators of P. Vreken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Vreken. P. Vreken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferrer, Isidró, Josef P. Kapfhammer, C. Hindelang, et al.. (2005). Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. Human Molecular Genetics. 14(23). 3565–3577. 86 indexed citations

Assies, Johanna, E.B. Haverkort, R. Lieverse, & P. Vreken. (2003). Effect of dehydroepiandrosterone supplementation on fatty acid and hormone levels in patients with X‐linked adrenoleucodystrophy. Clinical Endocrinology. 59(4). 459–466. 15 indexed citations

Kuilenburg, André B. P., Rutger Meinsma, P. Vreken, Hans R. Waterham, & Albert H. Gennip. (2002). Isoforms of Human CTP Synthetase. Advances in experimental medicine and biology. 486. 257–261. 16 indexed citations

Ferdinandusse, Sacha, et al.. (2002). Stereochemistry of the peroxisomal branched-chain fatty acid α- and β-oxidation systems in patients suffering from different peroxisomal disorders. Journal of Lipid Research. 43(3). 438–444. 42 indexed citations

Moolenaar, Sytske H., Udo F. H. Engelke, Manfred Spraul, et al.. (2001). β‐Ureidopropionase deficiency: A novel inborn error of metabolism discovered using NMR spectroscopy on urine. Magnetic Resonance in Medicine. 46(5). 1014–1017. 43 indexed citations

Tang, Nelson L.S., Joannie Hui, L. K. Law, et al.. (2001). Overview of common inherited metabolic diseases in a Southern Chinese population of Hong Kong. Clinica Chimica Acta. 313(1-2). 195–201. 12 indexed citations

Kuilenburg, André B. P., Janet Haasjes, Dick J. Richel, et al.. (2000). Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.. Data Archiving and Networked Services (DANS). 6(12). 4705–12. 307 indexed citations

Kuilenburg, André B. P., Rutger Meinsma, P. Vreken, Hans R. Waterham, & Albert H. Gennip. (2000). Identification of a cDNA encoding an isoform of human CTP synthetase. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1492(2-3). 548–552. 24 indexed citations

Ommen, C. Heleen van, et al.. (2000). Carbohydrate-deficient glycoprotein syndrome type 1a: A variant phenotype with borderline cognitive dysfunction, cerebellar hypoplasia, and coagulation disturbances. The Journal of Pediatrics. 136(3). 400–403. 25 indexed citations

10.

Vreken, P., André B. P. Kuilenburg, Naoki Hamajima, et al.. (1999). cDNA cloning, genomic structure and chromosomal localization of the human BUP-1 gene encoding β-ureidopropionase. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1447(2-3). 251–257. 30 indexed citations

11.

Bootsma, Albert H., Henk Overmars, Arno van Rooij, et al.. (1999). Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: Application for selective screening of peroxisomal disorders. Journal of Inherited Metabolic Disease. 22(3). 307–310. 71 indexed citations

12.

Wanders, Ronald J. A., et al.. (1998). X‐linked adrenoleukodystrophy: Improved prenatal diagnosis using both biochemical and immunological methods. Journal of Inherited Metabolic Disease. 21(3). 285–287. 5 indexed citations

13.

Kuilenburg, André B. P., P. Vreken, L.V.A.M. Beex, Ronney A. De Abreu, & Albert H. Gennip. (1998). Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G -> A point mutation (vol 21, pg 280, 1998). Journal of Inherited Metabolic Disease. 21(7). 1 indexed citations

14.

Vreken, P., André B. P. Kuilenburg, Rutger Meinsma, et al.. (1998). Dihydropyrimidine dehydrogenase deficiency: A novel mutation and expression of missense mutations in E. coli. Journal of Inherited Metabolic Disease. 21(3). 276–279. 21 indexed citations

15.

Hamajima, Naoki, P. Vreken, Satoshi Sumi, et al.. (1998). Dihydropyrimidinase Deficiency: Structural Organization, Chromosomal Localization, and Mutation Analysis of the Human Dihydropyrimidinase Gene. The American Journal of Human Genetics. 63(3). 717–726. 53 indexed citations

16.

Kuilenburg, André B. P., P. Vreken, L.V.A.M. Beex, Ronney A. De Abreu, & Albert H. Gennip. (1998). Severe 5‐fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G→A point mutation. Journal of Inherited Metabolic Disease. 21(3). 280–284. 10 indexed citations

17.

Vreken, P., H. P. Rusch, Karin Huijben, & Ron A. Wevers. (1998). Anion‐exchange chromatography versus isoelectric focusing of transferrin in diagnosing the carbohydrate‐deficient glycoprotein syndrome. Journal of Inherited Metabolic Disease. 21(4). 447–448. 1 indexed citations

18.

Kuilenburg, André B. P., P. Vreken, L.V.A.M. Beex, et al.. (1997). Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity. European Journal of Cancer. 33(13). 2258–2264. 90 indexed citations

19.

Vreken, P., et al.. (1995). A Point Mutation in an Invariant Splice Acceptor Site Results in a Decreased mRNA Level in a Patient with Severe Coagulation Factor XIII Subunit A Deficiency. Thrombosis and Haemostasis. 74(2). 584–589. 26 indexed citations

20.

Galego, Lisete, Isabel Barahona, Claudina Rodrigues‐Pousada, et al.. (1993). Known heat‐shock proteins are not responsible for stress‐induced rapid degradation of ribosomal protein mRNAs in yeast. Yeast. 9(6). 583–588. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact